Moreover, the vascularity and tumor proliferation, as evaluated by CD34 (p = 0.0021) and KI-67 (p = 0.0451) staining, respectively, were higher in the CCL2-Vehicle group than in the Mock-Vehicle group (Fig. 6D,E). This evidence concerns the gene CCL2 and neoplasm.